underlying malignancy and its response to therapy would determine the outcome, with pulmonary in¬ filtrates representing a terminal complication. In the latter, pulmonary infiltrates would bear their own specific prognostic implications. It is evident that the answer to these questions would directly affect clin¬ ical decision-making procedures in this difficult clin¬ ical setting.
However, the available information about prog¬ nostic factors associated with the outcome of pulmo¬ nary infiltrates in this patient population is scarce.
Few studies have addressed this issue at all, and most of these were not primarily designed as prognostic analyses.13-6 Accordingly, multivariate analyses were not usually performed.
We therefore designed a study to determine the precise prognostic significance of both, the factors that reflect the underlying malignancy and response to therapy as well as the factors that reflect the severity of the pulmonary complication.
changed, and an empiric antimycotic regimen (amphotericin B±frucytosine) was added. In addition, CT scans of the chest were performed to look for patterns of (Fig 1) . The probability of a 10-day survival in cases of a positive ratio was 30%, whereas it was still 58% in patients with neutropenia at the end point.
DISCUSSION
The most important findings of our study were as follows: (1) 
